ADP-ribosylation-like factor 6 interacting protein 6 pseudogene

This target is a human pseudogene, i.e., a gene-like DNA sequence that resembles a functional ancestral gene (ADP-ribosylation-like factor 6 interacting protein 6) but contains disabling mutations that prevent it from encoding a functional protein[1][2][3]. Pseudogenes are sometimes transcribed into RNA and can occasionally have regulatory roles—such as acting as competing endogenous RNAs (ceRNAs) or microRNA decoys—but are usually not considered candidates for drug targeting, and most have no known biological or clinical function[2][3]. There is no evidence that this pseudogene is used as a drug target, biomarker, or therapeutic intervention point. This entity is a pseudogene and is not a functional protein, enzyme, receptor, transporter, or drug target. While pseudogenes may in rare cases influence biological processes via RNA regulation, the majority—including this one—are not pharmacological or clinical targets[1][2][3].